1. Home >
  2. Companies >
  3. PE Backed >
  4. Life Science >
  5. Italy >
  6. Neopharmed Gentili >
  7. M&A

Neopharmed Gentili Mergers & Acquisitions

Neopharmed Gentili M&A Summary

Neopharmed Gentili has acquired 2 companies of its own, including 1 in the last 5 years.

Neopharmed Gentili’s largest acquisition to date was in 2025, when it acquired European Orladeyo Berotralstat business for $264M. Neopharmed Gentili has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Neopharmed Gentili

Neopharmed Gentili S.p.A.

Via San Giuseppe, Cottolengo 15,
Milan, 20143
Italy,
+39 0289132600
www.neogen.it

All (2) Buy (2) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-06-27 European Orladeyo Berotralstat business · Life Science
Durham, North Carolina

European Orladeyo Berotralstat business offers a focused portfolio and infrastructure dedicated to the prevention of hereditary angioedema attacks. European Orladeyo Berotralstat business is based in Durham, North Carolina.

264 Divestiture

Neopharmed Gentili
Advisors: Centerview Partners , White & Case

BioCryst Pharmaceuticals
Advisors: BofA Securities , Skadden, Arps, Slate, Meagher & Flom


Try Mergr Free — See This and 221,316+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal